top of page
Hormone Testing for Women: Which Test, Which Day, and Why? — Ozark Holistic Center

Hormone Testing for Women: Which Test, Which Day, and Why?

Writer: Dr. Orie Quinn
Dr. Orie Quinn
11 minutes ago
5 min read

When I think about hormone testing, I start with the question we need to answer. Are we looking for evidence of ovulation? Investigating missing periods? Assessing androgen-related symptoms? Trying to understand a menopause transition that began unusually early? Each question may require different tests, different timing, or no hormone test at all.


A broad panel can produce a long report without resolving the problem that brought you to care. The useful result is one that helps distinguish possible explanations or changes what happens next. There is no single panel that establishes whether all of your hormones are “balanced.”


Begin with the clinical question


For irregular or absent periods, evaluation may begin with pregnancy testing and a review of medications, contraception, and menstrual history. Depending on the situation, a clinician may assess thyroid function, prolactin, FSH, estradiol, or androgens. These tests answer different questions and should not automatically be ordered as an identical package for everyone. [1]


In possible PCOS, the assessment combines clinical features with selected tests and sometimes imaging. In suspected endometriosis, blood reproductive hormone levels do not provide the diagnosis. In a typical menopause transition after age 45, the history often provides more useful diagnostic information than routine FSH or estradiol testing. [2,3,4]


Match the collection time to the purpose


Progesterone testing for recent ovulation is usually timed for roughly one week before the expected next period. That timing can differ considerably from cycle day 21. A low result collected before ovulation is expected and cannot answer the question the same way as a properly timed post-ovulation sample. [1]


FSH and estradiol used in some fertility assessments may be measured early in the cycle. Other tests follow different rules. With an irregular cycle or no bleeding, a clinician may need a different collection plan rather than asking you to guess the appropriate day. [1]


Time of day also matters for certain hormones. Cortisol testing may involve a scheduled blood or saliva sample, a urine collection over time, or a suppression or stimulation protocol. A random cortisol value is not a general measure of how stressed you feel. [5]


Our approach: follow the pattern with Mira


Reproductive hormones have traditionally been evaluated with blood tests. At Ozark Holistic Center, Dr. Quinn uses daily at-home urine hormone testing with Mira when the goal is to understand patterns across the menstrual cycle. In Dr. Quinn’s clinical experience, that ongoing view has been more informative than relying on one blood-test snapshot.


Depending on the wand, Mira can measure LH, FSH, E3G, and PdG. E3G is an estrogen metabolite and PdG is a progesterone metabolite. These urine values are not interchangeable with blood estradiol or progesterone concentrations. [6,7]


We interpret the chart alongside symptoms, bleeding, medications, and your goals. Consistent collection and a testing schedule suited to the question matter. Targeted blood work still has a role—for example, when assessing thyroid function, prolactin, androgens, or another concern that cycle tracking cannot answer.


You can find Mira devices on our Shop page. We can help you choose a tracking plan and understand what the results mean for your care.


See how these questions differ in our guides to progesterone testing, PCOS assessment, and low estrogen symptoms.


The sample changes what is measured


A result is a clue with limits


An LH surge can suggest that ovulation is approaching, but it does not prove that an egg was released. Baseline LH patterns can make home tests harder to interpret in some people with PCOS. [1]


A progesterone sample can support evidence of recent ovulation, while a single value cannot reliably grade overall luteal function. AMH can provide information relevant to ovarian reserve and treatment planning, but it does not measure egg quality or guarantee present or future fertility. [1,8]


A laboratory reference range is also not a universal target for how you should feel. Results need the correct units, assay context, timing, and clinical interpretation. Comparing your number with someone else's screenshot may obscure more than it explains.


The useful result is one that helps distinguish possible explanations or changes what happens next.

Prepare information that makes testing more useful


Bring the dates of recent bleeding, the symptoms you want addressed, and a list of medications and supplements. Include hormonal contraception and any hormones prescribed elsewhere. Ask whether anything you take can affect the test, and follow the clinician's instructions rather than stopping medication on your own. [9]


Before ordering, ask what a high, low, or expected result would change. Would it lead to a second test, imaging, treatment, or reassurance? If every possible result would lead to the same advice, the test may have limited value for that particular question.


You can also ask for a plain-language interpretation of the actual report. Understanding why a test was chosen and what it cannot establish makes the results easier to use. The aim is a clearer decision about your health, rather than the largest possible collection of numbers.


Questions about your hormones? Let’s talk about where to begin.


If you are unsure which hormone questions need testing, we can talk about the information that would be useful. Learn about our functional medicine approach in Fayetteville, Arkansas, or schedule a free 15-minute consultation to ask whether an appointment is a good fit.


For a closer look at home monitoring, read why I use daily hormone data in conversations about the cycle.



About the author: Orie Quinn, D.C., is the founder, chiropractor, and Certified Functional Medicine Clinician at Ozark Holistic Center in Fayetteville, Arkansas.


Sources & further reading


  1. ASRM Practice Committee. Fertility evaluation of infertile women. Committee opinion. 2021. Clinical guidance on targeted testing, timing and interpretation.

  2. Teede HJ et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS. Human Reproduction. 2023. Diagnostic criteria, metabolic assessment and individualized management.

  3. Becker CM et al. ESHRE guideline endometriosis. Human Reproduction Open. 2022;hoac009. Clinical guideline for diagnostic pathways and management.

  4. NICE. Menopause identification and management. Guideline NG23. Current recommendations. Clinical identification, selective testing and treatment context.

  5. MedlinePlus. Cortisol Test. Clinical indications, collection methods and timing.

  6. Pilot Evaluation of a New Urine Progesterone Test to Confirm Ovulation in Women Using a Fertility Monitor. Frontiers in Public Health. 2019;7:184. Small pilot study of urinary PdG; not validation of every consumer monitor or diagnosis.

  7. Mira. What fertility hormones does Mira measure. Manufacturer specifications only; not independent evidence of clinical efficacy.

  8. ASRM Practice Committee. Diagnosis and treatment of luteal phase deficiency. Committee opinion. 2026. Progesterone variability and limitations of luteal assessment.

  9. MedlinePlus. Progesterone Test. Test purpose, collection and pregnancy context.


Prepared for Dr. Quinn’s review. Original source review: October 14, 2026. Luteal-phase committee-opinion reference updated to its 2026 edition.

 
 
bottom of page